IPH (IPH) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
13 Jun, 2025Transaction overview
IPH Limited is acquiring 100% of Bereskin & Parr LLP for CAD 82.5m (approx. AUD 90.2m), with 70% paid in cash and 30% in scrip, subject to a two-year escrow.
The acquisition is expected to close in late September 2024, pending regulatory and customary approvals.
Bereskin & Parr will be integrated into IPH’s Smart & Biggar business, enhancing scale and presence in Canada.
The deal is expected to be low single-digit EPS accretive on a pro-forma FY24 basis with full run-rate synergies.
Net debt/pro forma FY24 EBITDA is projected at approximately 1.7x post-transaction.
Strategic rationale and integration
Bereskin & Parr is a leading Canadian IP firm with a strong reputation, blue-chip client base, and over 40% client retention for more than 10 years.
The acquisition is highly complementary to Smart & Biggar, offering a full suite of IP services and opportunities for cost synergies and cross-selling.
Integration will focus on combining back-office functions and leveraging the IPH network for outbound Canadian filings.
Expected full run-rate synergies of CAD 3.7m are targeted in the first full financial year post-acquisition.
IPH has a strong track record of successful integration of previous Canadian acquisitions.
Equity raising and funding
IPH is conducting a fully underwritten AUD 100m institutional placement and a non-underwritten share purchase plan (SPP) targeting up to AUD 25m.
Proceeds will fund the cash component of the acquisition and reduce debt.
The offer price for the placement is AUD 5.65 per share, a 7.1% discount to the last close.
SPP shares will be issued at AUD 5.46, reflecting the offer price less the final dividend.
Macquarie Capital and Barrenjoey Markets are joint lead managers and underwriters for the placement.
Latest events from IPH
- Earnings and cash flow rose, driven by Canada and Asia, with ANZ impacted by US PCT declines.IPH
H1 202619 Feb 2026 - Strong FY24 growth, Canadian expansion, and improved leverage support future outlook.IPH
H2 202423 Jan 2026 - Strong growth, Canadian expansion, and transformation initiatives drive future momentum.IPH
AGM 202414 Jan 2026 - Underlying EBITDA up 11% and net profit up 20% on strong growth and integration.IPH
H1 202523 Dec 2025 - Revenue up 16.5% to AUD 710.3m, with cost savings and Canadian integration driving future growth.IPH
H2 202523 Nov 2025 - Profit growth, board renewal, and CEO succession amid U.S. and Canadian market challenges.IPH
AGM 202520 Nov 2025 - Market-leading IPH Limited drives growth through innovation, efficiency, and global expansion.IPH
Company Presentation6 Jun 2025